This list shows content tagged with the following label:
To add a label to the list of required labels, choose '+ labelname' from Related Labels.
-
IRB Member Considerations When Evaluating Reported Events as Possible Unanticipated Problems (Office of Human Subjects Research Protections)
-
IRB Member Considerations when Reviewing Criteria for IRB Approval of Research Protocols Minimizing Risk and the Risk vs. Benefit Assessment (Office of Human Subjects Research Protections)
-
How to Receive Email Updates About FDA Drug Label Changes (Office of Human Subjects Research Protections)
-
-